Results of GM-CSF treatment in chemotherapeutic extravasation ulcers

Journal of B.U.ON.

Volumn 15, Issue 3, 2010, Pages 608-609

  Vargel, I ^a   Canter, Halil Ibrahim ^b   Erdem, A ^c   Altundag, M K ^d  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b ACIBADEM UNIVERSITY   (Turkey)

^c Bursa State Hospital   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

CANCER CHEMOTHERAPY; CANCER PATIENT; DEBRIDEMENT; EXTRAVASATION; HUMAN; INJECTION SITE EXTRAVASATION; LETTER; SKIN ULCER; SURGICAL TECHNIQUE; TISSUE INJURY; TISSUE NECROSIS; WOUND HEALING;

EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; ULCER;

EID: 77957725882     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Rudolph R, Larson DL. Etiology and treatment of chemotherapeutic agent extravasation injuries: a review. J Clin Oncol 1987; 5: 1116-1126.
2. Ener RA, Meglathery SB, Styler M. Extravasation of systemic hemato-oncological therapies. Ann Oncol 2004; 15: 858-862. (Pubitemid 39004339)
3. Khan MS, Holmes JD. Reducing the morbidity from extravasation injuries. Ann Plast Surg 2002; 48: 628-632.
4. Bekerecioglu M, Kutluhan A, Demirtas I, Karaayvaz M. Prevention of adriamycin-induced skin necrosis with various free radical scavengers. J Surg Res 1998; 75: 61-65.
5. Vargel I, Erdem A, Ertoy D et al. Effect of growth factors on doxorubicin-induced skin necrosis: documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF. Ann Plast Surg 2002; 49: 646-653. (Pubitemid 35403216)